Business Context and Reporting Period
This Form 8-K reports the consummation of the Initial Public Offering (IPO) by Blue Water Acquisition Corp. IV, a Cayman Islands-based special purpose acquisition company (SPAC). The report covers events occurring between March 19, 2026 (pricing and agreements) and March 23, 2026 (closing of the IPO).
Key Financial Metrics
- Units Sold: 13,000,000 Units in the IPO (including 500,000 from over-allotment) and 425,000 Private Units.
- Offering Price: $10.00 per Unit.
- Gross Proceeds (IPO): $130,000,000.
- Private Placement Proceeds: $4,250,000 (275,000 Units to Sponsor; 150,000 Units to BTIG).
- Trust Account Deposit: $130,000,000 (includes $4,550,000 in deferred underwriting commissions).
- Warrant Exercise Price: $11.50 per share.
- Revenue/Profit/Cash Flow: The filing does not provide historical revenue, profit, or operating cash flow data as the company is a pre-business combination SPAC.
Material Changes
The primary material change is the transition from a private entity to a publicly traded company on the New York Stock Exchange (NYSE) under the symbols BWIV (shares), BWIV.U (units), and BWIV.WS (warrants). The company has established a trust account holding the IPO proceeds to fund a future business combination.
Guidance, Outlook, and Risks
- Outlook: The company is seeking an initial business combination. No specific target or timeline for a merger is provided in this filing.
- Lock-up Period: Holders of Private Units agreed not to transfer or sell their securities until 30 days after the completion of the initial business combination.
- Contingencies: The warrants are redeemable and subject to adjustment. The deferred underwriting commission of $4,550,000 is contingent upon the completion of a business combination.
- Management Changes: Treavor L. Hawkins, Timothy N. Coulson, and Laurent D. Hermouet were appointed as independent directors on March 19, 2026.
Investor Verification Checklist
- Verify the audited balance sheet to be filed within four business days of March 23, 2026, confirming the exact cash position in the trust account.
- Review the Underwriting Agreement (Exhibit 1.1) for details on the deferred underwriting commission and underwriter obligations.
- Examine the Amended and Restated Memorandum and Articles of Association (Exhibit 3.1) for specific redemption rights and liquidation preferences.
- Confirm the identity and background of the newly appointed independent directors via the Registration Statement.
- Monitor future filings for the identification of a target company for the initial business combination.